Mechanism of pathological aging of brain by using transgenic mice

转基因小鼠大脑病理性衰老机制

基本信息

  • 批准号:
    10832002
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

We first examined transgenic mice (Tg) expressing human βAPP695 ΔNL (APPsw mice : Hsiao K et al. Science 1996) to clarify the character of amyloid β protein (Aβ) deposited in brains of these mice. In 8-month-old mice, giant cored plaques (CP) appeared in the hippocampus and the cerebral cortex. Diffuse plaques (DP) and amyloid angiopathy (AA) in some small vessels of cerebral cortex and subaracnoidal space were recognized in 12-month-old mice, and increased with age. These neuropathological structures consisted of various Aβ species with both N-and C- terminal modifications such as those of AD brains. Accumulation of hyperphosphorylated tau as well as _βAPP were observed in dystrophic neurites surrounding CP. Neuronal cell loss as well as synaptic loss were found in cored plaques. The substantial amounts of Aβ40 and Aβ42 in brains at the age of 8 months were detected, and remarkably increased with the evolution of Aβ amyloidosis. Passive avoidance test revealed that these mice have significant memory impairment at the age of 8.5 months. Thus, APPsw mice are useful models for examining the mechanism of AD pathology.Next, to clarify whether Apolipoprotein E(ApoE) promotes deposition of Aβ in vivo, we examined both brains and plasma of Tg that coexpress APPsw and rat Apo E (corresponding to human ApoE4)((βAPP(+)ApoE(+) Tg). There were no differences in the degree of CP, DP, and AA of between βAPP(+)ApoE(+) Tg and βAPP(+)ApoE(-) Tg at the age of 4 and 8 months. However, at the age of 12 months, degree of CP, DP, and AA in βAPP(+)ApoE(+) Tg was greater than those of βAPP(+)ApoE(-) Tg. The levels of both Aβ40 and Aβ42 in brains of βAPP(+)ApoE(+) Tg were higher than those of βAPP(+)ApoE(-) Tg by 12% and 60%, respectively. Furthermore, the levels of Aβ40 in plasma of βAPP(+)ApoE(+) Tg were also higher than those of βAPP(+)ApoE(-) Tg by 40%. Thus, those findings suggest that ApoE accelerates Aβ deposition by increasing Aβ concentration.
我们首先检查了表达人β APP 695 ΔNL的转基因小鼠(Tg)(APPsw小鼠:Hsiao K et al. Science 1996),以阐明沉积在这些小鼠脑中的淀粉样β蛋白(Aβ)的特征。在8个月大的小鼠中,海马和大脑皮层出现了巨大的核心斑块(CP)。12月龄小鼠大脑皮质和蛛网膜下腔的部分小血管出现弥漫性斑块(DP)和淀粉样血管病(AA),并随年龄增加而增多。这些神经病理学结构由具有N-和C-末端修饰的各种Aβ物质组成,如AD脑的那些。CP周围神经突起内存在过度磷酸化的tau蛋白和βAPP。在核心斑块中发现神经元细胞丢失以及突触丢失。8月龄时脑内Aβ40和Aβ42的含量已达高峰,并随Aβ淀粉样变性的进展而显著增加。被动回避实验显示,这些小鼠在8.5月龄时有明显的记忆障碍。接下来,为了阐明载脂蛋白E(ApoE)是否促进体内Aβ沉积,我们检查了共表达APPsw和大鼠Apo E(对应于人ApoE 4)((βAPP(+)ApoE(+)Tg)的Tg的脑和血浆。βAPP(+)ApoE(+)Tg与β APP(+)ApoE(-)Tg在4月龄和8月龄时的CP、DP和AA程度无差异。但12个月龄时,βAPP(+)Apoe(+)Tg的CP、DP和AA程度大于βAPP(+)Apoe(-)Tg。βAPP(+)ApoE(+)Tg组脑内Aβ40和Aβ42水平分别比βAPP(+)ApoE(-)Tg组高12%和60%。此外,βAPP(+)ApoE(+)Tg组血浆Aβ40水平也比βAPP(+)ApoE(-)Tg组高40%。因此,这些发现表明ApoE通过增加Aβ浓度加速Aβ沉积。

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shizuka M, Shoji M, et al.: "A novel mutation of the myelin P(o) gene segregating Charcot-Marie-Tooth disease type 1B manifesting as trigeminal nerve thickening."J Neurol Neurosurg Psychiatry. 67. 250-1 (1999)
Shizuka M、Shoji M 等人:“髓磷脂 P(o) 基因的一种新突变使 1B 型夏科-马里-图思病分离,表现为三叉神经增厚。”J Neurol Neurosurg Psychiatry。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomidokoro Y,Harigaya Y,et al: "Carboxyl-terminal fragments'of presenilin-1 are dosely related to cytoskeletal abnormalities in Alzheimer's brains"Biochem Biophys Res Commum. 256. 512-518 (1999)
Tomidokoro Y、Harigaya Y 等人:“早老素-1 的羧基末端片段与阿尔茨海默病大脑中的细胞骨架异常密切相关”Biochem Biophys Res Commum。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shoji M,Harigaya Y,et al: "Distribution of amyloid βprotein precursor in the Alzheimer's disease brain"Psychiatry and Clinical neurosciences. 54. 45-54 (2000)
Shoji M、Harigaya Y 等人:“淀粉样 β 蛋白前体在阿尔茨海默病大脑中的分布”《精神病学和临床神经科学》54. 45-54 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
東海林幹夫: "アルツハイマー病の動物モデル-解明点と問題点.井原康夫編 新臨床医のための分子医学シリーズ" 羊土社, (1999)
Mikio Tokaibayashi:“阿尔茨海默病的动物模型 - 澄清和问题的要点。由 Yasuo Ihara 编辑。新临床医生的分子医学系列”Yodosha,(1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kanai M.,Harigaya Y.et al.: "Apolipoprotein E4 accelerates dementia and increases cerebrospinal tau levels in Alzeimer's disease"Neurosci. Lett.. 267. 65-68 (1999)
Kanai M.、Harigaya Y. 等人:“载脂蛋白 E4 会加速痴呆并增加阿尔茨海默氏病的脑脊髓 tau 水平”Neurosci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HARIGAYA Yasuo其他文献

HARIGAYA Yasuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HARIGAYA Yasuo', 18)}}的其他基金

Development of study curriculum and evaluation method for "Production and measurement/control" corresponding to new technology
开发与新技术对应的“生产与测量/控制”学习课程和评价方法
  • 批准号:
    20500773
  • 财政年份:
    2008
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of accumulation of amyloid and neurofibrillary tangles in Alzheimer's disease brain
阿尔茨海默病大脑中淀粉样蛋白和神经原纤维缠结的积累机制
  • 批准号:
    12670593
  • 财政年份:
    2000
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
  • 批准号:
    10696442
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Modelling mechanisms of progressive chronic kidney disease in APOL1 high-risk live-donors using BAC-Transgenic mice
使用 BAC 转基因小鼠模拟 APOL1 高危活体供体的进行性慢性肾病的机制
  • 批准号:
    10726804
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Cholesterol-related genes in response to brain deafferentation in normal and transgenic mice
胆固醇相关基因对正常和转基因小鼠脑传入神经阻滞的反应
  • 批准号:
    RGPIN-2020-04702
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
Elucidation of the pathophysiology of schizophrenia / autism spectrum disorder using EP400 gene transgenic mice
使用 EP400 基因转基因小鼠阐明精神分裂症/自闭症谱系障碍的病理生理学
  • 批准号:
    22K07582
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the acute cognitive outcomes of repetitive mild traumatic brain injury in transgenic mice
研究转基因小鼠重复性轻度创伤性脑损伤的急性认知结果
  • 批准号:
    486121
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Studentship Programs
Cholesterol-related genes in response to brain deafferentation in normal and transgenic mice
胆固醇相关基因对正常和转基因小鼠脑传入神经阻滞的反应
  • 批准号:
    RGPIN-2020-04702
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
Development of transgenic mice to visualize mitochondrial stress for understanding the pathogenesis of age-related diseases
开发转基因小鼠来可视化线粒体应激,以了解与年龄相关的疾病的发病机制
  • 批准号:
    21K15377
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development and preclinical testing in human cell models and transgenic mice of a novel treatment for Schinzel-Giedion Syndrome
辛泽尔-吉迪翁综合征新疗法的开发和在人类细胞模型和转基因小鼠中的临床前测试
  • 批准号:
    430820
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Operating Grants
Analysis of Psmb8 mutation-transgenic mice, model of Nakajo-Nishimura syndrome
Psmb8 突变转基因小鼠 Nakajo-Nishimura 综合征模型分析
  • 批准号:
    19K08780
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol-related genes in response to brain deafferentation in normal and transgenic mice
胆固醇相关基因对正常和转基因小鼠脑传入神经阻滞的反应
  • 批准号:
    RGPIN-2020-04702
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了